Joseph A, Biji M, Murali V, Sherin D, Valsan A, Sukumaran V
RSC Med Chem. 2024; .
PMID: 39246746
PMC: 11378019.
DOI: 10.1039/d4md00318g.
Craig O, Lee S, Pilcher C, Saoud R, Abdirahman S, Salazar C
NAR Genom Bioinform. 2024; 6(3):lqae096.
PMID: 39184376
PMC: 11344246.
DOI: 10.1093/nargab/lqae096.
Zhao J, Zhao X, Gao J, Bai B, Niu J, Yang Y
J Anim Sci. 2024; 102.
PMID: 38902909
PMC: 11245705.
DOI: 10.1093/jas/skae173.
Shen H, Hung C, Davis C, Su C, Liao L, Shih H
Biomolecules. 2024; 14(5).
PMID: 38785978
PMC: 11118508.
DOI: 10.3390/biom14050571.
Zhou H, Wang Y, Wang T, Wu W, Cao Y, Zhang B
Oncol Lett. 2024; 27(5):206.
PMID: 38516683
PMC: 10956385.
DOI: 10.3892/ol.2024.14339.
Anticancer Effect of Theranekron on Androgen-Dependent Prostate Cancer Cells.
Erzurumlu Y, Kubra Dogan H, Catakli D
Turk J Pharm Sci. 2024; 20(6):368-373.
PMID: 38254333
PMC: 10803929.
DOI: 10.4274/tjps.galenos.2023.47905.
HERPUD1, a Member of the Endoplasmic Reticulum Protein Quality Control Mechanism, may be a Good Target for Suppressing Tumorigenesis in Breast Cancer Cells.
Erzurumlu Y, Doganlar Y, Kubra Dogan H, Catakli D
Turk J Pharm Sci. 2023; 20(3):157-164.
PMID: 37417198
PMC: 10337018.
DOI: 10.4274/tjps.galenos.2022.71643.
Cyclin O promotes lung cancer progression and cetuximab resistance via cell cycle regulation and interaction.
Jiang J, Yu W, Fang T, Li Y, Liang J, Zhao R
J Thorac Dis. 2023; 15(4):2167-2183.
PMID: 37197505
PMC: 10183503.
DOI: 10.21037/jtd-23-437.
MiR-17- 5p/RRM2 regulated gemcitabine resistance in lung cancer A549 cells.
Ma X, Fu T, Ke Z, Du S, Wang X, Zhou N
Cell Cycle. 2023; 22(11):1367-1379.
PMID: 37115505
PMC: 10228408.
DOI: 10.1080/15384101.2023.2207247.
miR-6087 Might Regulate Cell Cycle-Related mRNAs During Cardiomyogenesis of hESCs.
Machado H, Bispo S, Dallagiovanna B
Bioinform Biol Insights. 2023; 17:11779322231161918.
PMID: 37020502
PMC: 10069004.
DOI: 10.1177/11779322231161918.
Microtubule Acetylation-Specific Inhibitors Induce Cell Death and Mitotic Arrest via JNK/AP-1 Activation in Triple-Negative Breast Cancer Cells.
Ahn S, Kwon A, Oh Y, Rhee S, Song W
Mol Cells. 2023; 46(6):387-398.
PMID: 36794420
PMC: 10258459.
DOI: 10.14348/molcells.2023.2192.
Preclinical evaluation of the ROCK1 inhibitor, GSK269962A, in acute myeloid leukemia.
Pan T, Wang S, Feng H, Xu J, Zhang M, Yao Y
Front Pharmacol. 2022; 13:1064470.
PMID: 36561342
PMC: 9763303.
DOI: 10.3389/fphar.2022.1064470.
SMN-deficient cells exhibit increased ribosomal DNA damage.
Karyka E, Berrueta Ramirez N, Webster C, Marchi P, Graves E, Godena V
Life Sci Alliance. 2022; 5(8).
PMID: 35440492
PMC: 9018017.
DOI: 10.26508/lsa.202101145.
Co-expression patterns explain how a basic transcriptional role for MYC modulates and MAPK pathways in colon and lung adenocarcinomas.
Kucherlapati M
Cell Cycle. 2022; 21(15):1619-1638.
PMID: 35438040
PMC: 9291661.
DOI: 10.1080/15384101.2022.2060454.
Screening and validation of reference genes for qRT-PCR of bovine skeletal muscle-derived satellite cells.
Wang G, Liang C, Li B, Du X, Zhang W, Cheng G
Sci Rep. 2022; 12(1):5653.
PMID: 35383222
PMC: 8983775.
DOI: 10.1038/s41598-022-09476-3.
Screening and verifying key genes with poor prognosis in colon cancer through bioinformatics analysis.
Dong B, Chai M, Chen H, Feng Q, Jin R, Hu S
Transl Cancer Res. 2022; 9(11):6720-6732.
PMID: 35117282
PMC: 8797306.
DOI: 10.21037/tcr-20-2309.
Targeting the mTOR Pathway in Hurthle Cell Carcinoma Results in Potent Antitumor Activity.
Dong Y, Gong Y, Kuo F, Makarov V, Reznik E, Nanjangud G
Mol Cancer Ther. 2021; 21(2):382-394.
PMID: 34789562
PMC: 8828689.
DOI: 10.1158/1535-7163.MCT-21-0224.
CYT387, a potent IKBKE inhibitor, suppresses human glioblastoma progression by activating the Hippo pathway.
Wang X, Lu J, Li J, Liu Y, Guo G, Huang Q
J Transl Med. 2021; 19(1):396.
PMID: 34544426
PMC: 8454155.
DOI: 10.1186/s12967-021-03070-3.
Simulated Microgravity Inhibits the Proliferation of Chang Liver Cells by Attenuation of the Major Cell Cycle Regulators and Cytoskeletal Proteins.
Ho C, Tran M, Doan C, Hoang S, Tran D, Le L
Int J Mol Sci. 2021; 22(9).
PMID: 33925309
PMC: 8123698.
DOI: 10.3390/ijms22094550.
Overexpression of EZH2/NSD2 Histone Methyltransferase Axis Predicts Poor Prognosis and Accelerates Tumor Progression in Triple-Negative Breast Cancer.
Gao B, Liu X, Li Z, Zhao L, Pan Y
Front Oncol. 2021; 10:600514.
PMID: 33665162
PMC: 7921704.
DOI: 10.3389/fonc.2020.600514.